Return to search results
Ramipril
Ramipril is a prescription medication that belongs to the class of angiotensin-converting enzyme (ACE) inhibitors. It helps treat high blood pressure and heart failure by relaxing blood vessels. Available as oral capsules in strengths of 1.25mg, 2.5mg, 5mg, and 10mg, manufactured by Lupin Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ramipril is a prescription medication that belongs to the class of angiotensin-converting enzyme (ACE) inhibitors. It helps treat high blood pressure and heart failure by relaxing blood vessels. Available as oral capsules in strengths of 1.25mg, 2.5mg, 5mg, and 10mg, manufactured by Lupin Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ramipril",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ramipril — ANDA 079116 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079116"
}
]
|
| identifier | ANDA079116 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ramipril |
